Vincristine sulfate liposome and its preparation method and application

A technology of vincristine sulfate and liposomes, which is applied in the directions of liposome delivery, pharmaceutical formulations, medical preparations of inactive ingredients, etc., can solve the problems of low stability of vincristine sulfate liposomes, etc. Anti-tumor effect, improving drug enrichment, protecting and stabilizing effect

Inactive Publication Date: 2020-08-18
GUANGXI MEDICAL UNIVERSITY
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved in the present invention is to provide a kind of vincristine sulfate liposome prepared by using sphingomyelin and its preparation method and application in view of the low stability of vincristine sulfate liposome prepared by conventional phospholipids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vincristine sulfate liposome and its preparation method and application
  • Vincristine sulfate liposome and its preparation method and application
  • Vincristine sulfate liposome and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0033] The present invention also provides the preparation steps and parameters of suitable vincristine sulfate liposomes especially for sphingomyelin, this is because the chemical structure and hydrophilicity of different phospholipids are different, and the performance of the drug wrapped is different, resulting in the present The steps and parameters for preparing and encapsulating antitumor drugs with other phospholipids in the prior art are not fully applicable to the present invention. see figure 1 , for the preparation method of the vincristine sulfate liposome according to the preferred embodiment of the present invention, the vincristine sulfate liposome as described above can be prepared. As shown in the figure, the preparation method includes:

[0034]First, in step S1, the sphingomyelin component, the cholesterol component and the phospholipid stabilizer are dissolved in an organic solvent in a molar ratio of 50-60:35-45:4-6 to prepare a blank liposome. Preferabl...

Embodiment 1

[0049] This embodiment 1 prepares vincristine sulfate liposome VCR-Lipo.

[0050] Preparation of S1, PEG long-circulating liposome (Lipo):

[0051] Egg sphingomyelin (SM), cholesterol (Cholesterol), and DSPE-PEG2000 dissolved in chloroform were added into a round-bottomed flask at a molar ratio of 55:40:5, and a rotary evaporator was used at 60°C at a speed of Rotate at 200rpm / min and turn on the vacuum pump to vacuum for 10min to form a dry film, and dry overnight in a vacuum dryer to remove residual organic solvents.

[0052] Among them, SM is the product of Avanti polar lipids company, the product number is 860061P; cholesterol is the product of Avantipolar lipids company, the product number is 700100P; DSPE-PEG2000 is the product of Avanti polar lipids company, the product number is 880128P.

[0053] The lipid film at the bottom of the bottle was hydrated with 1 ml of 300 mM citrate buffer (pH=4.0), and after ultrasonication in a 50°C water bath for 20 min, it was repeate...

Embodiment 2

[0057] This embodiment 2 prepares vincristine sulfate liposome VCR-Lipo.

[0058] Preparation of S1, PEG long-circulating liposome (Lipo):

[0059]Egg sphingomyelin (SM), cholesterol (Cholesterol), and DSPE-PEG2000 dissolved in chloroform were added into a round-bottomed flask in a molar ratio of 50:45:4. Rotate at 100rpm / min and turn on the vacuum pump to vacuum for 20min to form a dry film, and dry overnight in a vacuum dryer to remove residual organic solvents.

[0060] Wherein raw material SM, cholesterol and the product that DSPE-PEG2000 selects for use are identical with embodiment 1.

[0061] The lipid film at the bottom of the bottle was hydrated with 1 ml of 300 mM citrate buffer (pH=4.0), and after ultrasonication in a 60°C water bath for 30 min, it was repeatedly frozen and thawed 6 times in liquid nitrogen and a 50°C water bath. The product is packed into a liposome pusher, passed through the polycarbonate membrane of 200nm and 100nm successively for 25 times, an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The present invention relates to a vincristine sulfate liposome and a preparation method thereof, wherein the vincristine sulfate liposome comprises vincristine sulfate and a nanometer liposome prepared from sphingomyelin, and the vincristine sulfate is wrapped in the nanometer liposome. According to the present invention, the nanometer liposome is prepared by using the sphingomyelin, and the vincristine sulfate liposome is prepared after the vincristine sulfate is wrapped, wherein the sphingomyelin contains more amide bonds so as to well resist chemical and biological degradation, protect the stability of the liposome structure, and improve the drug enrichment of tumor cells, such that the antitumor effect is improved.

Description

technical field [0001] The invention relates to a drug delivery system for cancer, more specifically, relates to a vincristine sulfate liposome, a preparation method and application. Background technique [0002] Vincristine sulfate (vincristine sulfate, VCR) is a cell cycle specific antineoplastic drug of apocynaceae vinca alkaloids. The target of antitumor effect is microtubules, mainly inhibiting the polymerization of tubulin and affecting the spindle. The formation of microtubules stops mitosis in metaphase. Like other vinca alkaloids, VCR has a good therapeutic effect on many lymphoid malignancies, including aggressive non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Clinically, it is mainly used in the treatment of acute leukemia, malignant lymphoma, neuroblastoma, chronic lymphocytic leukemia and other diseases. Although VCR has good anti-tumor effect, the clinical application of VCR is limited due to its rapid metabolism in vivo, short half-life, high neuro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/127A61K31/475A61K47/24A61K47/28A61P35/00
CPCA61K9/127A61K31/475A61K47/24A61K47/28
Inventor 赵永祥卢小玲
Owner GUANGXI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products